ApyraVax - Live Attenuated Typhoid Vaccine

The ApyraVax technology exploits the live attenuated typhoid vaccine as vector to deliver orally an enzyme that breaks down ATP (apyrase) together with desired antigen/s. The innovative feature is the unique ability to generate high-affinity secretory IgA that are protective towards the target infectious agent.